ENFORTUMAB VEDOTIN

enfortumab vedotin 20 mg injection, 1 vial

ENFORTUMAB VEDOTIN (15513L)

15513L
Body System:
Manner of administration:Injection
Public
Chemotherapy Items for Public Hospital use
Authority Required (STREAMLINED)

Restriction (Streamlined authority code: 19195)

Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer

Restriction (Streamlined authority code: 19060)

Indication: Locally advanced (Stage III) or metastatic (Stage IV) urothelial cancer
Treatment phase: Grandfather arrangement - Transitioning from non-PBS to PBS-subsided treatment
Quantities & Cost
Max amount # of repeats DPMA Max safety net General Patient Charge
Max amount: 125 mg # of repeats: 7 DPMA: $6,215.95 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Padcev
(enfortumab vedotin 20 mg injection, 1 vial)
Padcev
(enfortumab vedotin 30 mg injection, 1 vial)